We are live on ! Find out more
ZLTQ

ZELTIQ Aesthetics, Inc.
ZLTQ

Delisted

ZLTQ was delisted on the 27th of April, 2017.

132 hedge funds and large institutions have $929M invested in ZELTIQ Aesthetics, Inc. in 2014 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 48 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $754M → $929M (+$175M)

4% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 48

4% less funds holding

Funds holding: 137132 (-5)

12% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 26

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

67% less call options, than puts

Call options by funds: $2.13M | Put options by funds: $6.44M

Holders
132
Holders Change
-5
Holders Change %
-3.65%
% of All Funds
3.52%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.13%
New
23
Increased
46
Reduced
48
Closed
26
Calls
$2.13M
Puts
$6.44M
Net Calls
-$4.32M
Net Calls Change
-$2.67M
Name Holding Trade Value Shares
Change
Change in
Stake
PC
26
Pier Capital
Connecticut
$9.19M -$172K -6,586 -2%
Northern Trust
27
Northern Trust
Illinois
$9M -$141K -5,427 -2%
QI
28
QS Investors
New York
$7.25M +$6.76M +259,614 New
GP
29
Grow Partners
California
$6.98M +$1.82M +70,000 +39%
Deutsche Bank
30
Deutsche Bank
Germany
$6.59M +$15.3K +586 +0.2%
Axa
31
Axa
France
$6.48M -$1.03M -39,700 -15%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$6.19M -$1.58M -60,610 -21%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$6.05M +$462K +17,751 +9%
ICRM
34
Insight Capital Research & Management
California
$5.6M +$5.22M +200,584 New
SC
35
Sophrosyne Capital
New York
$5.38M -$5M -191,821 -50%
ACP
36
Arrowgrass Capital Partners
United Kingdom
$5.07M
OAM
37
Oxford Asset Management
United Kingdom
$4.98M -$7.98M -306,432 -63%
TCM
38
Timpani Capital Management
Wisconsin
$4.83M +$2.57M +98,734 +133%
SCM
39
Sandler Capital Management
New York
$4.73M -$1.32M -50,600 -23%
BA
40
BlackRock Advisors
Delaware
$4.47M +$1.39M +53,491 +50%
GTC
41
Ghost Tree Capital
New York
$4.47M -$391K -15,000 -9%
CCM
42
Cadence Capital Management
Massachusetts
$4.25M -$128K -4,934 -3%
EI
43
EAM Investors
California
$4M +$818K +31,402 +28%
USAA
44
United Services Automobile Association
Texas
$3.75M -$1.3M -49,739 -27%
RFC
45
Russell Frank Company
Washington
$3.1M +$271K +10,396 +10%
WCM
46
Washington Capital Management
Washington
$2.89M -$348K -13,360 -11%
TCIM
47
TIAA CREF Investment Management
New York
$2.85M -$468K -17,959 -15%
LCG
48
Lisanti Capital Growth
New York
$2.82M -$302K -11,595 -10%
OCM
49
OMT Capital Management
California
$2.81M -$3.31M -127,170 -56%
Morgan Stanley
50
Morgan Stanley
New York
$2.61M +$1.2M +46,264 +98%

ZLTQ Hedge Fund Activity: Q4 2014 in Review

132 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in ZELTIQ Aesthetics, Inc. (ZLTQ) for Q4 2014, worth a combined $929M — up 23% from $754M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of ZLTQ and 23 opened new positions — a net loss of 3 holders — while 48 trimmed existing stakes and 46 added.

The largest buyer was Millennium Management, adding an estimated $23.9M. The largest seller was March Altus Capital Management, exiting entirely with an estimated $12.2M sold.

  • 132 institutional investors held ZELTIQ Aesthetics, Inc. (ZLTQ) as of Q4 2014, down from 137 in Q3 2014.
  • Funds reported $929M of ZELTIQ Aesthetics, Inc. stock for Q4 2014, up 23% quarter-over-quarter.
  • 23 funds opened new ZELTIQ Aesthetics, Inc. positions in Q4 2014 and 26 closed out, a net change of -3 holders.
  • The largest ZELTIQ Aesthetics, Inc. buyer in Q4 2014 was Millennium Management, an estimated $23.9M added.
  • The largest ZELTIQ Aesthetics, Inc. seller in Q4 2014 was March Altus Capital Management, an estimated $12.2M sold.

Based on aggregated 13F filings for Q4 2014.